Michael P Schön Selected Research

Eosinophilic Fasciitis

12/2021	Response of recalcitrant generalized morphea to intravenous immunoglobulins (IVIg): three cases and a review of the literature.
8/2021	Response of eosinophilic fasciitis associated with Waldenström macroglobulinemia to rituximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael P Schön Research Topics

Disease

34	Neoplasms (Cancer) 12/2021 - 08/2003
30	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 04/2002
28	Melanoma (Melanoma, Malignant) 01/2023 - 01/2002
20	Inflammation (Inflammations) 01/2022 - 04/2002
15	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2002
7	Atopic Dermatitis (Atopic Eczema) 12/2020 - 04/2004
7	Skin Neoplasms (Skin Cancer) 01/2012 - 01/2002
6	Skin Diseases (Skin Disease) 12/2020 - 02/2011
6	Contact Dermatitis (Eczema, Contact) 11/2020 - 11/2005
5	Hypersensitivity (Allergy) 05/2021 - 01/2007
4	Lichen Planus (Lichen Ruber Planus) 01/2022 - 05/2011
3	Pityriasis Rubra Pilaris 01/2024 - 08/2021
3	Multiple Sclerosis 01/2021 - 02/2016
3	Hemangioma (Angioma) 01/2020 - 03/2010
3	Basal Cell Carcinoma (Rodent Ulcer) 01/2020 - 07/2010
3	Carcinogenesis 08/2015 - 09/2007
3	Xeroderma Pigmentosum (Kaposi's Disease) 07/2013 - 03/2011
2	Darier Disease (Darier's Disease) 12/2022 - 09/2003
2	Benign Familial Pemphigus (Hailey Hailey Disease) 12/2022 - 12/2014
2	Mycosis Fungoides 07/2022 - 10/2009
2	Pyoderma 01/2022 - 01/2022
2	Rheumatoid Arthritis 01/2022 - 09/2008
2	Wounds and Injuries (Trauma) 01/2022 - 02/2018
2	Eosinophilic Fasciitis 12/2021 - 08/2021
2	COVID-19 01/2020 - 01/2020
2	Pruritus (Itching) 01/2020 - 09/2003
2	Allergic Contact Dermatitis 01/2019 - 02/2014
2	Actinic Keratosis 01/2016 - 08/2003
1	Breakthrough Infections 10/2023
1	Exanthema (Rash) 01/2023
1	Infections 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Arthritis (Polyarthritis) 01/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2007
11	CytokinesIBA 01/2020 - 08/2003
9	LigandsIBA 12/2021 - 08/2003
8	Interleukin-17 (Interleukin 17)IBA 01/2020 - 02/2011
7	Imiquimod (Aldara)FDA LinkGeneric 01/2007 - 01/2002
6	IntegrinsIBA 12/2021 - 04/2010
6	SelectinsIBA 04/2007 - 04/2002
5	AntibodiesIBA 09/2017 - 08/2005
4	AllergensIBA 01/2021 - 11/2005
4	CalcineurinIBA 01/2020 - 03/2011
4	AntigensIBA 01/2019 - 02/2010
4	P-SelectinIBA 02/2010 - 11/2005
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
3	upadacitinibIBA 01/2022 - 12/2021
3	Irritants (Vesicants)IBA 05/2021 - 12/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 06/2011
3	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 09/2007
3	InterleukinsIBA 07/2018 - 03/2007
3	Phosphotransferases (Kinase)IBA 12/2016 - 04/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2014 - 08/2003
3	MART-1 AntigenIBA 01/2014 - 06/2002
3	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2012 - 06/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 03/2011
2	bimekizumabIBA 01/2024 - 12/2023
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2022
2	CalciumIBA 12/2022 - 11/2022
2	ChemokinesIBA 01/2022 - 09/2008
2	Cadherins (E-Cadherin)IBA 12/2021 - 01/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 12/2021 - 01/2012
2	risankizumabIBA 08/2021 - 10/2020
2	Propranolol (Inderal)FDA LinkGeneric 01/2020 - 03/2010
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 08/2015
2	HaptensIBA 01/2019 - 12/2015
2	Immunoglobulin E (IgE)IBA 01/2019 - 01/2016
2	FibrinIBA 02/2018 - 09/2013
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2016 - 04/2010
2	FumaratesIBA 02/2016 - 12/2011
2	1- O- octadecyl- 2- O- (2- inositolylethyl)- glycero- 3- phosphatidylcholineIBA 10/2014 - 02/2014
2	Platelet Activating FactorIBA 10/2014 - 02/2011
2	Adalimumab (Humira)FDA Link 02/2014 - 09/2008
2	ErbB Receptors (EGF Receptor)IBA 01/2014 - 09/2007
2	Methoxsalen (Oxsoralen)FDA Link 03/2012 - 06/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2012 - 06/2006
2	Green Fluorescent ProteinsIBA 02/2012 - 02/2010
2	Cytostatic AgentsIBA 04/2010 - 06/2008
2	Monoclonal AntibodiesIBA 04/2010 - 09/2008
2	NF-kappa B (NF-kB)IBA 04/2010 - 06/2008
2	Death Domain ReceptorsIBA 05/2004 - 08/2003
1	Immunoglobulin G (IgG)IBA 10/2023
1	mogamulizumabIBA 01/2023
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 12/2022
1	Adenosine Triphosphatases (ATPase)IBA 12/2022
1	Proto-Oncogene Proteins B-rafIBA 11/2022
1	AntioxidantsIBA 11/2022
1	dabrafenibIBA 01/2022
1	trametinibIBA 01/2022
1	Tissue Adhesives (Tissue Adhesive)IBA 01/2022
1	tofacitinibIBA 01/2022

Therapy/Procedure

34	Therapeutics 01/2023 - 09/2003
7	Drug Therapy (Chemotherapy) 01/2023 - 06/2008
5	Dye Lasers 01/2020 - 10/2009
4	Heterologous Transplantation (Xenotransplantation) 08/2014 - 11/2007
3	Immunotherapy 01/2023 - 11/2021
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2019 - 01/2016
2	Solid-State Lasers 06/2014 - 12/2013
2	Radiotherapy 04/2011 - 07/2010
1	Investigational Therapies (Experimental Therapy) 01/2023